Preferential Activity of <i>Petiveria alliacea</i> Extract on Primary Myeloid Leukemic Blast

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_center" colspan="4">Cell lines (IC<sub>50</sub>)</td></tr><tr class="thead"><td class="align_left">Treatments</td><td class="align_center">K562</td><td class="align_center">U937</td><td class="align_center">Jurkat</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Anamu SC (<i>μ</i>g/mL)</td><td class="align_center">75.4 ± 9.3</td><td class="align_center">96.14 ± 1.4</td><td class="align_center">13.14 ± 4.1</td></tr><tr><td class="align_left">P2Et (<i>μ</i>g/mL)</td><td class="align_center">154.6 ± 21.4</td><td class="align_center">102.3 ± 14.5</td><td class="align_center">49.5 ± 2.4</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Cytotoxic activity of the extracts on the tumor lines: K562, U937, and Jurkat.</div>

Evidence-Based Complementary and Alternative Medicine

tab3

Table 3

Table 3: Preferential Activity of <i>Petiveria alliacea</i> Extract on Primary Myeloid Leukemic Blast 

Evidence-Based Complementary and Alternative Medicine

Preferential Activity of Petiveria alliacea Extract on Primary Myeloid Leukemic Blast

Table 3